Gypenosides ameliorate high-fat diet-induced non-alcoholic steatohepatitis via farnesoid X receptor activation
Hongshan Li(United States Food and Drug Administration), Xin Xin(Shanghai University of Traditional Chinese Medicine), Hongliang Liu(Unknown), Yingfei Xi(University of Chinese Academy of Sciences)
Cited by 30
Related Papers
FDA Approval Summary: Olaparib Monotherapy in Patients with Deleterious Germline <i>BRCA</i>-Mutated Advanced Ovarian Cancer Treated with Three or More Lines of Chemotherapy
|Clinical Cancer Research|2015|526
Magnetic field sensor based on magnetic fluid clad etched fiber Bragg grating
|Optical Fiber Technology|2011|168
Stress-constrained topology optimization based on maximum stress measures
|Computers & Structures|2018|139
Identifying diffused nitrate sources in a stream in an agricultural field using a dual isotopic approach
|The Science of The Total Environment|2014|118
Ability of prebiotic polysaccharides to activate a HIF1α-antimicrobial peptide axis determines liver injury risk in zebrafish
|Communications Biology|2019|117